Sort by
Refine Your Search
-
have a postgraduate degree, ideally a doctoral degree, in a relevant field and experience in computer-based analyses and presentation of experimental data. The successful applicant would have a proven
-
impacts in the UK. Candidates should have a postgraduate (ideally post-doctoral) degree in epidemiology, medical statistics, public health or similar, and have knowledge of climate change adaptation and
-
the EPIC project funded by Reckitt and by ICA project funded by RGHI. It is available from 1 October 2025. The salary will be on the LSHTM salary scale, Grade 6 in the range £45,097 - £51,156 per annum pro
-
reviewing, and quantitative and qualitative data analysis. The post-holder must have a postgraduate degree, ideally a doctoral degree, in a relevant topic. The post-holder should have an in-depth knowledge
-
collaboration with partners in The Gambia, Ghana, Nepal, Brazil, and the UK. The successful applicant will have a postgraduate degree, ideally a doctoral degree, in a relevant field and experience conducting
-
measures to assess these risks. Priority will be given to applications focusing on planetary health solutions (adaptation, mitigation or both). The post-holder must have a postgraduate degree, ideally a
-
degree, ideally a PhD, in health economics, medical statistics, data science, epidemiology or a related field. A clear conceptual understanding of causal inference methods such as instrumental variable
-
will join a highly successful and supportive TB modelling group, with scope to take initiative for research within the field. The post-holder must have a postgraduate degree, ideally a doctoral degree
-
, Professors Ruth Keogh and Kate Walker. Applicants should have a postgraduate degree, ideally a PhD, in medical statistics, epidemiology, health economics or a related field. Relevant experience in applying
-
PhD) while conducting highly policy relevant research. Applicants should have a postgraduate degree with MRCP or MRCS. Relevant clinical experience in providing cancer treatments, co-ordinating clinical